In a new job - November 17, 2025
Jan Lundberg joins SmartCella’s Scientific Advisory Board
“With his track record of turning science into life-changing medicines, he brings rigor and vision to help shape our strategy for the next generation of therapies. This week’s SAB focused on how to best prioritize the broad potential of mRNA as a therapeutic modality. There was a wealth of creative thinking, including considerations of when […]
In a new job - November 17, 2025
Bavarian Nordic’s Chair of the Board steps down
The company's Chair of the Board, Luc Debruyne has decided to step down from the board with immediate effect.
Financing - November 17, 2025
Vicore Pharma raises approximately USD 48 million
Vicore Pharma Holding has completed a directed share issue through which the company raises gross proceeds of approximately USD 48 million (approximately SEK 455 million) before deduction of transaction costs.
Biotech Business - November 17, 2025
PeptiSystems secures investment from Rubicon Healthcare Partners
The partnership will enable PeptiSystems to accelerate its global expansion and deliver scalable, next-generation manufacturing solutions to a rapidly growing biopharma market, it states.
In a new job - November 15, 2025
New members elected to Novo Nordisk’s Board of Directors
On November 14, Novo Nordisk held its Extraordinary General Meeting, which was convened to elect new members of the Board of Directors.
Global report - November 15, 2025
MSD to acquire Cidara Therapeutics for USD 9.2 billion
Merck (known as MSD outside of the United States and Canada), and Cidara Therapeutics, a biotech company developing drug-Fc conjugate (DFC) therapeutics, have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Cidara for a total transaction value of approximately USD 9.2 billion.
